CHUSPAN SCS BP Treatment of Churg-Strauss Syndrome Without Poor-Prognosis Factors
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To assess the efficacy of systemic corticosteroids alone as first-line treatment of
Churg-Strauss syndrome without poor-prognosis factors as defined by the five-factor score
(FFS=0), and to compare the efficacy and safety of azathioprine vs pulse cyclophosphamide as
adjunctive immunosuppressive therapy to treat failure or relapse